Annotated Bibliography Amazon Malaria Initiative Products Links Media, LLC 707 Conservation Drive, Suite 300 Gaithersburg, MD 20878 T: 301-987-5495 F: 301-987-5498 www.linksmedia.net April 2011 This report was made possible through support provided by the United States Agency for International Development, under the terms of Contract No. GHS-I-372-03-00037-00. The author’s views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or the United States Government. About Links Media Links Media is a full-service communications company providing organizations with an array of technologies and methods to influence behavior, communicate risk, and mobilize resources to generate positive change. Links Media’s services include market research, strategic communications, multimedia production, partnership building and advocacy, and knowledge dissemination. Currently, Links Media is leading communication and advocacy efforts in support of the United States Agency for International Development’s Amazon Malaria Initiative. Recommended Citation Links Media. 2011. Annotated Bibliography: Amazon Malaria Initiative. Submitted to the U.S. Agency for International Development. Gaithersburg, MD: Links Media, LLC. AMI Annotated Bibliography • Links Media Page i Table of Contents Technical Reports and Training Manuals ................................................................................ 1 Selected Trip Reports, Activity Reports, Progress Reports, and Work Plans .......................... 14 Journal Articles .................................................................................................................... 30 Brief Reports, Graphics, and Fact Sheets .............................................................................. 31 Other Printed Materials ....................................................................................................... 35 Selected Presentations ........................................................................................................ 37 Presentations at the VII Technical Meeting of the Amazon Malaria Initiative ....................................... 37 Presentations at the Malaria in the Americas: A Disease Without Borders—Malaria Day in the Americas 2008 ......................................................................................................................................... 40 Presentations at the Malaria Control is a Social Responsibility—Malaria Day in the Americas 2008 ... 41 Presentations at the VIII Technical Meeting of the Amazon Malaria Initiative ...................................... 41 Presentations at the IX Technical Meeting of the Amazon Malaria Initiative, Santa Cruz, Bolivia, March 2–5, 2010. ............................................................................................................................................... 46 Presentations at the 37th Annual International Conference on Global Health: Global Health Goals & Metrics, June 14–18, 2010, Washington, DC .......................................................................................... 53 Presentations at Malaria in the Americas Forum, November 4, 2010, Washington, D.C. ...................... 53 Presentations at the Training Sessions: Planning, Implementing and Promoting an AMI/RAVREDA Event for Malaria Day in the Americas 2010 .......................................................................................... 54 Presentations at World Malaria Day 2010 ............................................................................................. 55 Presentations at the X Technical Meeting of the Amazon Malaria Initiative, Panama City, Panama, March 22–24, 2011 ................................................................................................................................. 55 Other Presentations ................................................................................................................................ 67 Success Stories .................................................................................................................... 68 Web Pages and Online Announcements ............................................................................... 69 News Releases and Other Media Materials .......................................................................... 71 Selected Media Coverage: Newspaper and Online News Articles ......................................... 78 Selected Media Coverage: Radio .......................................................................................... 83 Selected Media Coverage: Television ................................................................................... 85 Videos and Photos ............................................................................................................... 86 AMI Annotated Bibliography • Links Media Page ii Technical Reports and Training Manuals Amazon Network for the Surveillance of Antimalarial Drug Resistance (RAVREDA). No date. Generic protocol for antimalarial drug-efficacy studies in the Americas. Washington, DC: Pan American Health Organization. http://www.paho.org/English/AD/DPC/CD/mal-GenericPf_MQ- AS_eng.doc (accessed June 19, 2009). This document is a generic research protocol for studies determining the efficacy and safety of mefloquine and mefloquine–artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria. It is intended to be adapted for use in different countries, departments, provinces, and states. In addition to the protocol itself, appendices provide drug dosage tables, a case report form, definitions of parasitological response, and consent and assent forms. Avecillas, José. 2009. Informe de evaluación de las prácticas de prescripción, dispensación, y adherencia al tratamiento antimalárico en Ecuador. (Evaluation report regarding prescription, dispensing, and adherence to antimalarial treatment in Ecuador.) Submitted to the U.S. Agency for International Development by the Strengthening Pharmaceutical Systems Program. Arlington, VA: Management Sciences for Health. (In Spanish.) A study performed by Management Sciences for Health/Strengthening Pharmaceutical Systems Program in Ecuador between December 2008 and the first week of March 2009 documented existing drug prescription and dispensing practices performed by health services in Ecuador, especially those in the country that contribute to reinforcing treatment adherence using antimalarial combination therapy. The study also documented current antimalarial drug prescription and dispensing practices at Servicio Nacional de Erradicación de la Malaria and Public Health Ministry Operational Units and assessed the impact of experiences that promote adherence to antimalarial treatment, with an effort to determine the impact of written instructions for patients on such adherence. Barillas, Edgar, Claudia Valdez, and Silas Holland. 2008. Situación de la gestión del suministro de medicamentos para el tratamiento de la malaria en los países que comparten la Cuenca Amazónica. (State of antimalarial drug supply management in countries that compose the Amazon Basin.) Submitted to the U.S. Agency for International Development by the Strengthening Pharmaceutical Systems Program. Arlington, VA: Management Sciences for Health. (In Spanish.) The countries that compose the Amazon Basin have undertaken various activities to improve the supply of medicines. However, no document consolidates information on the state of medicine supply management or summarizes the achievements made to date. From October 2007 to July 2008, the Strengthening Pharmaceutical Systems Program conducted short visits to Brazil (October 2007), Bolivia and Ecuador (January 2008), Guyana (March 2008), Peru (April 2008), Colombia (May 2008), and Suriname (July 2008) to learn about the state of antimalarial supply management, the improvements introduced in the system as a result of the technical assistance by the Amazon Malaria Initiative, and the problems that must still be addressed in the next few years. This document collects the principal findings of those visits. AMI Annotated Bibliography • Links Media Page 1 Barillas, Edgar, Claudia Valdez, and Silas Holland. 2008. State of malaria pharmaceutical management in the Amazon Basin countries. Submitted to the U.S. Agency for International Development by the Strengthening Pharmaceutical Systems Program. Arlington, VA: Management Sciences for Health. The countries that compose the Amazon Basin have undertaken various activities to improve the supply of medicines. However, no document consolidates information on the state of medicine supply management or summarizes the achievements made to date. From October 2007 to July 2008, the Strengthening Pharmaceutical Systems Program conducted short visits to Brazil (October 2007), Bolivia and Ecuador (January 2008), Guyana (March 2008), Peru (April 2008), Colombia (May 2008), and Suriname (July 2008) to learn about the state of antimalarial supply management, the improvements introduced in the system as a result of technical assistance by the Amazon Malaria Initiative, and the problems that must still be addressed in the next few years. This document collects the principal findings of those visits. Briggs, J., and Edgar Barillas. 2009. Informe de estudio sobre la disponibilidad de medicamentos para tratar “casos especiales” de malaria en Suramérica y Centroamérica. (Study report regarding drug availability for treating “special cases” of malaria in South and Central America.) Submitted to the U.S. Agency for International Development by the Strengthening Pharmaceutical Systems Program. Arlington, VA: Management Sciences for Health. (In Spanish.) In 2007 and 2008, the Strengthening Pharmaceutical Systems (SPS) program, implemented by Management Sciences for Health, performed quick evaluations in seven countries including the Amazon Basin countries, Nicaragua, and Guatemala. These evaluations showed a periodic lack of antimalarial supplies for treating “special cases” of malaria. In this context, “special cases” of malaria are defined as severe cases where treatment has failed, as well as malaria cases during pregnancy. The number of malaria cases has decreased significantly in the majority of these countries resulting in a significant reduction in “special cases” of the disease. This has also led to fewer local providers being interested in selling the small quantities of antimalarials that are necessary to treat such cases. The SPS program decided to document the problem in Amazon Malaria Initiative countries and Central America, and presented preliminary results at the opportunity afforded by a regional meeting that took place in Guatemala, on November 2007, to discuss antimalarial supply management in Central America. Espinoza, Henry. 2008. Situación del almacenamiento de medicamentos e insumos médicos antimaláricos en las bodegas de Guayaquil y Machala del SNEM del Ministerio de Salud del Ecuador. (State of storage of antimalarial drugs and medical supplies, in SNEM/Ecuadorean Health Ministry facilities in Guayaquil and Machala.) Submitted to the U.S. Agency for International Development by the Strengthening Pharmaceutical Systems Program. Arlington, VA: Management Sciences for Health. (In Spanish.) In May 2008, Management Sciences for Health/Strengthening Pharmaceutical Systems organized a regional workshop to analyze common management problems in the antimalarial drug supply chain. National teams of participating countries compiled a preliminary draft for standard antimalarial drug supply management procedures and put forth specific technical AMI Annotated Bibliography • Links Media Page 2 assistance requests to improve drug management. In Ecuador, storage systems are one of the main weaknesses in the supply of antimalarial drugs. This report presents an evaluation of Servicio Nacional de Erradicación de la Malaria storage systems in Guayaquil and Machala, as well as findings, identified problems, and short-term proposals for improvement. Hinestroza, Yenifer. 2009. Informe sobre la implementación de la prueba piloto para la aplicación de un instrumento estandarizado en la supervisión del suministro y uso de medicamentos e insumos contra la malaria en Colombia: Enero 2009. (Report regarding the implementation of pilot tests for applying a standard document for supervising the supply and use of antimalarial drugs and supplies in Colombia: January 2009.) Submitted to the U.S. Agency for International Development by the Strengthening Pharmaceutical Systems Program. Arlington, VA: Management Sciences for Health. (In Spanish.) The U.S. Agency for International Development Mission in the Dominican Republic is supporting antimalarial medication and medical supply management. With the support of partner organizations such as the Amazon Malaria Initiative (AMI), including the Pan American Health Organization (PAHO) and Management Sciences for Health (MSH), an oversight form was developed and tested in a pilot program (in coordination with the Social Protection Ministry and the National Health Institute) during August and November 2008. This oversight form demonstrated the feasibility of obtaining useful information (not available through other sources) for resolving problems at local and departmental levels. The results were formally discussed with higher officials of the national malaria control program and the Social Protection Ministry, who then evaluated the extent of the form’s application in the rest of the country. AMI (through MSH and PAHO) will continue providing whatever technical assistance may be required to institutionalize this practice. Links Media. 2010. The Amazon Malaria Initiative: Goals and Accomplishments, October 2001–May 2009. Submitted to the U.S. Agency for International Development by Links Media Gaithersburg, MD: Links Media (ed.) with contributions from the Centers for Disease Control and Prevention, Management Sciences for Health, Pan American Health Organization, Research Triangle Institute, and U.S. Pharmacopeia. (In English.) http://www.usaidami.org/extras/AMIMultiyearReport_06212010.pdf (accessed on May 18, 2011) The Amazon Malaria Initiative (AMI) partners have compiled The Amazon Malaria Initiative: Goals and Accomplishments, a multiyear report which summarizes important information about this initiative from October 2001 to May 2009. This report explains AMI’s subregional approach, which has promoted evidence-based decision making in the Amazon Basin region and fosters multicountry collaboration. Additionally, it reports on the needs, activities, and major accomplishments within the AMI technical areas: antimalarial medicine resistance; diagnostic quality assurance and access to diagnosis; antimalarial medicine quality; antimalarial medicine access and use; vector control, insecticide resistance, and entomology; and communication and information dissemination. AMI Annotated Bibliography • Links Media Page 3 Management Sciences for Health. 2008. Building Local Coalitions for Containing Drug Resistance: A Guide. Submitted to the U.S. Agency for International Development by the Rational Pharmaceutical Management Plus Program. Arlington, VA: Management Sciences for Health. http://www.usaidami.org/extras/BuildingLocalCoalitions.pdf (accessed November 23, 2010). This document aims to help AMR stakeholders organize a collaborative effort to address drug resistance locally. This guide shows users how to mobilize local support around drug resistance, gather credible evidence to guide decision making, and build consensus among AMR stakeholders on the nature of the problem to form a coalition. Management Sciences for Health/Amazon Malaria Initiative. 2010. Sistematización de estudios de adherencia al tratamiento antimalárico realizados en los países que comparten la Cuenca del Amazonas durante el periodo 2004–2009. (Systematization of studies of adherence to malaria treatment conducted in the countries that share the Amazon Basin during the period 2004–2009.) Submitted to the U.S. Agency for International Development by the Strengthening Pharmaceutical Systems Program. Arlington, VA: Management Sciences for Health. (In English and Spanish.) http://www.usaidami.org/extras/EstudiosDeAdherenciaAMI_En.pdf (accessed November 30, 2010). (In English.) http://www.usaidami.org/extras/EstudiosAdherenciaAMI.pdf (accessed November 30, 2010). (In Spanish.) This report describes the results of the studies presented during the workshop on improving prescription and dispensing practices and adherence to antimalarial treatment held in Rio de Janeiro, Brazil, from July 28–30, 2009. It discusses interventions that can contribute to improving the prescribing and dispensing of antimalarials, as well as patient adherence to antimalarial treatment, as identified in studies conducted in Amazon Malaria Initiative member countries over the 2004–2009 period. Ministry of Health of Bolivia. 2010. Bolivia Report—RAVREDA 2010. Presented on behalf of the Ministry of Health and Sports of Bolivia at the IX Technical Meeting of the Amazon Malaria Initiative, Santa Cruz, Bolivia, March 2–5, 2010. (In Spanish.) http://www.usaidami.org/extras/informebolivia.pdf (accessed November 30, 2010). This report describes the progress of the activities of the Amazon Malaria Initiative and RAVREDA during March 2009 until March 2010 in Bolivia. It provides statistics and indicators about malaria cases, reports improving in diagnosis quality management, antimalarial drugs monitoring and availability, antimalarial quality, vector control, entomological surveillance, implementation of long lasting impregnated bednets by area, insecticide resistance surveillance, and use and analysis of the information. Ministry of Health of Colombia. 2010. Colombia Report—RAVREDA 2010. Presented on behalf of the Ministry of Social Protection of Colombia at the IX Technical Meeting of the Amazon Malaria Initiative, Santa Cruz, Bolivia, March 2–5, 2010. (In Spanish.) http://www.usaidami.org/extras/informecolombia.pdf (accessed November 30, 2010). This report describes the progress of the activities of the Amazon Malaria Initiative and AMI Annotated Bibliography • Links Media Page 4 RAVREDA during March 2009 until March 2010 in Colombia. It analyses the malaria situation in this country, including distribution of malaria cases, antimalarial resistance surveillance, quality diagnosis, monitoring and availability of antimalarials, diagnosis and treatment quality, vector control, entomological surveillance, implementation of long lasting impregnated bednets by area, and use and analysis of the information. Ministry of Health of Ecuador 2010. Ecuador Report—RAVREDA 2010. Presented on behalf of the Ministry of Health of Ecuador at the IX Technical Meeting of the Amazon Malaria Initiative, Santa Cruz, Bolivia, March 2–5, 2010. (In Spanish.) http://www.usaidami.org/extras/informeecuador.pdf (accessed November 30, 2010). This report describes the progress of activities of the Amazon Malaria Initiative and RAVREDA during March 2009 until March 2010 in Ecuador. It provides statistics and indicators about malaria cases, reports on improving diagnosis quality management, antimalarial drugs monitoring and availability, antimalarial quality, vector control, entomological surveillance, implementation of long lasting impregnated bednets by area, insecticide resistance surveillance, and use and analysis of the information. Ministry of Health of Guyana. 2010. Guyana Report—RAVREDA 2010. Presented on behalf of the Ministry of Health of Guyana at the IX Technical Meeting of the Amazon Malaria Initiative, Santa Cruz, Bolivia, March 2–5, 2010. http://www.usaidami.org/extras/informeguyana.pdf (accessed November 30, 2010). This report describes the progress of activities of the Amazon Malaria Initiative and RAVREDA during March 2009 until March 2010 in Guyana. It includes general description of malaria in Guyana, quality of diagnosis, monitoring of the resistance to the antimalarials, quality of antimalarials, vector control, and analysis and use of information. Ministry of Health of Honduras. 2010. Honduras Report—RAVREDA 2010. Presented on behalf of the Ministry of Health of Honduras at the IX Technical Meeting of the Amazon Malaria Initiative, Santa Cruz, Bolivia, March 2–5, 2010. (In Spanish.) http://www.usaidami.org/extras/informehonduras.pdf (accessed November 30, 2010). This report describes the progress of activities of the Amazon Malaria Initiative and RAVREDA during March 2009 until March 2010 in Honduras. It provides statistics and indicators about malaria cases, reports improving in diagnosis quality management, antimalarial drugs monitoring and availability, antimalarial quality, vector control, entomological surveillance, implementation of long lasting impregnated bednets by area, insecticide resistance surveillance, and use and analysis of the information. Ministry of Health of Peru. 2010. Peru Report—RAVREDA 2010. Presented on behalf of the Ministry of Health of Peru at the IX Technical Meeting of the Amazon Malaria Initiative, Santa Cruz, Bolivia, March 2–5, 2010. (In Spanish.) http://www.usaidami.org/extras/informeperu.pdf (accessed November 30, 2010). This report describes the progress of activities of the Amazon Malaria Initiative and RAVREDA during March 2009 until March 2010 in Peru. It provides statistics and indicators about malaria cases, reports improving in diagnosis quality management, antimalarial drug AMI Annotated Bibliography • Links Media Page 5 monitoring and availability, antimalarial quality, vector control, entomological surveillance, implementation of long lasting impregnated bednets by area, insecticide resistance surveillance, and use and analysis of the information. Neyra, Daniel. 2009. Estudio sobre uso de medicamentos antimaláricos y aplicación de encuesta de adherencia—RAVREDA en Perú. (Study regarding the use of antimalarial drugs and the application of the adherence survey—RAVREDA in Peru.) Submitted to the U.S. Agency for International Development by the Strengthening Pharmaceutical Systems Program. Arlington, VA: Management Sciences for Health. (In Spanish.) Assessments were made to determine the consistency of the attributes for each of the proposed indicators, together with its corresponding collection instrument, within the context of the objectives for applying instruments for the Study of Antimalarial Drug Use (EUM) and EUM indicators used. As described in this report, the authors found that the indicators that need development are those related to (i) EESS efficiency for antimalarial treatment management and oversight (TAM); (ii) percentages of TAM stoppage within EESS; (iii) availability of national technical norms (TN) and/or Standard Malaria Treatment Guidance (SMTG) at healthcare facilities; (iv) correct TAM prescription adherence by healthcare personnel according to TN and SMTG; (v) EESS compliance in prescribing TAM correctly according to TN and SMTG; (vi) adequate and correct dispensing of TAM according to each prescription; (vii) TAM adherence based on information given during prescription and avoiding lost opportunities; (viii) ability of healthcare providers to give out information regarding the use of TAM medications; (ix) ability of healthcare providers for identifying a severe or complicated malaria alert; (x) ability of healthcare providers for advising patients regarding clinical signs of severe malaria or malaria emergency, and referral to other levels of treatment; (xi) therapeutic error tracking by healthcare providers, and the state of total patient adherence to antimalarial treatment. Pan American Health Organization. 2002. I Reunión Técnica de Coordinación de la Red Amazónica de Vigilancia de la Resistencia de los Antimaláricos (RAVREDA) y de la Iniciativa de Malaria en la Amazonía (AMI), Santa Cruz, Bolivia, 19–20 marzo de 2002. (I Technical Coordination Meeting of the Amazon Network for the Surveillance of Antimalarial Drug Resistance (RAVREDA) and the Amazon Malaria Initiative (AMI), Santa Cruz, Bolivia, 19–20 March 2002.) OPS/HCP/HCT/219/2002. Washington, DC: Pan American Health Organization. http://www.ops-oms.org/Spanish/AD/DPC/CD/reunion2002.htm (accessed June 19, 2009). (In Spanish.) This report describes the First Technical Coordination Meeting of RAVREDA and AMI, which took place in Santa Cruz, Bolivia, March 19–20, 2002. The meeting was attended by representatives from the Pan American Health Organization (PAHO), World Health Organization, U.S. Agency for International Development, the Centers for Disease Control and Prevention (CDC), and the eight Amazon countries participating in RAVREDA and AMI. During the two-day meeting, participants shared and discussed general project-related issues (e.g., objectives, priorities, expected results, and partners’ roles) as well as activities of the regional workplans of PAHO and CDC, country workplans for the first year, policy reform regarding antimalarial drug treatment schemes, and research priorities. AMI Annotated Bibliography • Links Media Page 6 Pan American Health Organization. 2002. I Technical Coordination Meeting of the Amazon Network for the Surveillance of Antimalarial Drug Resistance (RAVREDA) and the Amazon Malaria Initiative (AMI), Santa Cruz, Bolivia, 19–20 March 2002. OPS/HCP/HCT/219/2002. Washington, DC: Pan American Health Organization. http://www.ops- oms.org/English/AD/DPC/CD/reunion2002.htm (accessed June 19, 2009). This report describes the First Technical Coordination Meeting of RAVREDA and AMI, which took place in Santa Cruz, Bolivia, March 19–20, 2002. The meeting was attended by representatives from the Pan American Health Organization (PAHO), World Health Organization, U.S. Agency for International Development, the Centers for Disease Control and Prevention (CDC), and the eight Amazon countries participating in RAVREDA and AMI. During the two-day meeting, participants shared and discussed general project-related issues (e.g., objectives, priorities, expected results, and partners’ roles) as well as activities of the regional workplans of PAHO and CDC, country workplans for the first year, policy reform regarding antimalarial drug treatment schemes, and research priorities. Pan American Health Organization. 2003. Practical guide for in vivo antimalarial drug-efficacy studies in the Americas. OPS/DPC/CD/240/03. Washington, DC: Pan American Health Organization. http://www.paho.org/English/AD/DPC/CD/guia-practica.pdf (accessed June 19, 2009). The purpose of the recommendations in this guide, which is based on recent experiences with antimalarial drug efficacy studies in South America, was to complement the World Health Organization guidelines and standardized protocols for in vivo drug efficacy studies. This guide, and the generic protocols described therein, should contribute to the successful implementation of in vivo studies and a surveillance system for antimalarial drug resistance in the Americas. The guide describes such steps as the preparation of the protocol, study site selection, training of the study team, patient enrollment and follow-up, and specific laboratory practices. Pan American Health Organization. 2006. Oficina de Trabalho em medição de níveis séricos de antimaláricos. (Workshop on the measurement of antimalarial serum levels.) Washington, DC: Pan American Health Organization. http://www.paho.org/Portuguese/AD/DPC/CD/ravreda- reuniao-niveis-sericos-resumo.doc (accessed June 19, 2009). (In Portuguese.) This document describes the activities that took place during a multiday training in laboratory procedures for measuring serum levels of antimalarials, which was supported by the Amazon Network for the Surveillance of Antimalarial Drug Resistance and the Amazon Malaria Initiative under CDC’s technical leadership. This training was in response to the demonstrated need for regional capacity building for measuring chloroquine serum levels in patients with therapeutic failure in order to complement future monitoring activities for patient response to this product. The workshop was held in Belém, Pará, Brazil, in 2006, with the support of the Ministry of Health and the Instituto Evandro Chagas and the participation of professionals from Bolivia, Brazil, Colombia, Ecuador, Peru, and Guyana. AMI Annotated Bibliography • Links Media Page 7
Description: